Back to search

Sweden· SE-20110322000047

Fyro 500 mg/50 mg Brustablett

A medicinal product containing acetylsalicylic acid + caffeine, registered in Sweden by Evolan Pharma AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedFyro 500 mg/50 mg BrustablettATC—REGISTER NO.SE-20110322000047PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Acetylsalicylic Acid + Caffeine
Manufacturer
Evolan Pharma AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20110322000047

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1c157047-b138-4c6f-a5aa-f5ccc6c84895
GET /v1/drugs/1c157047-b138-4c6f-a5aa-f5ccc6c84895?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "PAR",
    "SmPC"
  ],
  "se_npl_id": "20110322000047",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20110322000047",
  "product_doc_link": "https://docetp.mpa.se/LMF/Fyro%20effervescent%20tablet%20SmPC_09001bee848f0c50.pdf"
}

See everything about acetylsalicylic acid + caffeine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.